Rare diseases
Investigational molecules
Locations
Zielstattstrasse 48, Thalk.Obersendl.-Forsten-Fuerstenr.-Solln, 81379 Munich, Germany
Research activity centers on lipid-lowering therapy and cardiovascular prevention, with attention to treatment combinations used in managing elevated cholesterol and broader atherosclerotic risk.
The sponsor’s clinical research includes fixed-dose combinations involving bempedoic acid, ezetimibe, and atorvastatin or rosuvastatin, reflecting a focus on therapies used in hyperlipidaemia management.
Daiichi Sankyo Europe GmbH runs clinical trials in conditions such as Arteriosclerosis coronary artery, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
